DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,015 filers reported holding DANAHER CORPORATION in Q3 2022. The put-call ratio across all filers is 1.00 and the average weighting 0.7%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $412,252 | -5.7% | 1,650 | -5.7% | 0.11% | -10.7% |
Q1 2024 | $437,010 | +7.9% | 1,750 | 0.0% | 0.12% | -3.2% |
Q4 2023 | $404,845 | -16.3% | 1,750 | -10.3% | 0.13% | -21.7% |
Q3 2023 | $483,795 | -10.4% | 1,950 | -13.3% | 0.16% | -2.4% |
Q2 2023 | $540,000 | -16.0% | 2,250 | -11.8% | 0.16% | -12.7% |
Q1 2023 | $642,702 | -5.0% | 2,550 | 0.0% | 0.19% | -10.4% |
Q4 2022 | $676,821 | -14.1% | 2,550 | -16.4% | 0.21% | -18.8% |
Q3 2022 | $788,000 | +1.9% | 3,050 | 0.0% | 0.26% | +7.4% |
Q2 2022 | $773,000 | -13.6% | 3,050 | 0.0% | 0.24% | +2.1% |
Q1 2022 | $895,000 | -17.6% | 3,050 | -7.6% | 0.24% | -11.9% |
Q4 2021 | $1,086,000 | +18.9% | 3,300 | +10.0% | 0.27% | +7.2% |
Q3 2021 | $913,000 | +54.7% | 3,000 | +36.4% | 0.25% | +41.0% |
Q2 2021 | $590,000 | +74.6% | 2,200 | +46.7% | 0.18% | +67.9% |
Q1 2021 | $338,000 | +1.5% | 1,500 | 0.0% | 0.11% | -3.6% |
Q4 2020 | $333,000 | +3.1% | 1,500 | 0.0% | 0.11% | -4.3% |
Q3 2020 | $323,000 | +21.9% | 1,500 | 0.0% | 0.12% | +15.0% |
Q2 2020 | $265,000 | +27.4% | 1,500 | 0.0% | 0.10% | +8.7% |
Q1 2020 | $208,000 | -9.6% | 1,500 | 0.0% | 0.09% | +9.5% |
Q4 2019 | $230,000 | +2.7% | 1,500 | -3.2% | 0.08% | -1.2% |
Q3 2019 | $224,000 | +0.9% | 1,550 | 0.0% | 0.08% | 0.0% |
Q2 2019 | $222,000 | +8.3% | 1,550 | 0.0% | 0.08% | +4.9% |
Q1 2019 | $205,000 | +28.1% | 1,550 | 0.0% | 0.08% | +12.5% |
Q4 2018 | $160,000 | -4.8% | 1,550 | 0.0% | 0.07% | +12.5% |
Q3 2018 | $168,000 | +9.8% | 1,550 | 0.0% | 0.06% | +3.2% |
Q2 2018 | $153,000 | +0.7% | 1,550 | 0.0% | 0.06% | -1.6% |
Q1 2018 | $152,000 | +5.6% | 1,550 | 0.0% | 0.06% | +8.6% |
Q4 2017 | $144,000 | +8.3% | 1,550 | 0.0% | 0.06% | +3.6% |
Q3 2017 | $133,000 | +1.5% | 1,550 | 0.0% | 0.06% | +3.7% |
Q2 2017 | $131,000 | +9.2% | 1,550 | +10.7% | 0.05% | +3.8% |
Q1 2017 | $120,000 | +10.1% | 1,400 | 0.0% | 0.05% | +4.0% |
Q4 2016 | $109,000 | -0.9% | 1,400 | 0.0% | 0.05% | -2.0% |
Q3 2016 | $110,000 | -22.0% | 1,400 | 0.0% | 0.05% | -22.7% |
Q2 2016 | $141,000 | +6.0% | 1,400 | 0.0% | 0.07% | +1.5% |
Q1 2016 | $133,000 | +375.0% | 1,400 | +366.7% | 0.06% | +400.0% |
Q4 2015 | $28,000 | +7.7% | 300 | 0.0% | 0.01% | 0.0% |
Q3 2015 | $26,000 | 0.0% | 300 | 0.0% | 0.01% | +8.3% |
Q2 2015 | $26,000 | +4.0% | 300 | 0.0% | 0.01% | +9.1% |
Q1 2015 | $25,000 | -3.8% | 300 | 0.0% | 0.01% | -8.3% |
Q4 2014 | $26,000 | +13.0% | 300 | 0.0% | 0.01% | +9.1% |
Q3 2014 | $23,000 | -25.8% | 300 | -25.0% | 0.01% | -26.7% |
Q2 2014 | $31,000 | – | 400 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ARTHUR M. COHEN & ASSOCIATES, LLC | 263,188 | $33,896,000 | 13.46% |
WALTER & KEENAN WEALTH MANAGEMENT LLC /IN/ /ADV | 263,188 | $33,896,000 | 13.46% |
Defender Capital, LLC. | 127,230 | $17,610,000 | 12.86% |
Eos Focused Equity Management, L.P. | 53,908 | $7,461,000 | 11.12% |
CORTLAND ASSOCIATES INC/MO | 419,035 | $57,999,000 | 10.88% |
Mirova US LLC | 477,368 | $66,072,000 | 8.75% |
Pactiv General Employee Benefit Trust | 579,300 | $80,181,000 | 8.58% |
Riverstone Advisors, LLC | 57,623 | $7,976,000 | 8.07% |
Eversept Partners, LP | 233,957 | $32,419,197 | 8.06% |
Third Point | 3,570,000 | $494,124,000 | 7.88% |